These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6165240)

  • 1. Erythrocytes as carriers of chemotherapeutic agents for targeting the reticuloendothelial system.
    Lynch WE; Sartiano GP; Ghaffar A
    Am J Hematol; 1980; 9(3):249-59. PubMed ID: 6165240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of erythrocytes for delivery of chemotherapeutic agents to the reticuloendothelial system.
    Lynch WE; Sartiano GP; Rosenblum SL; Calkins JH; Ramsey CB
    Bibl Haematol; 1985; (51):42-9. PubMed ID: 2408600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
    Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
    J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug loaded erythrocytes: as novel drug delivery system.
    Patel PD; Dand N; Hirlekar RS; Kadam VJ
    Curr Pharm Des; 2008; 14(1):63-70. PubMed ID: 18220819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principle products used in chemotherapy. Administration methods].
    Boillon C; Olivro A; Lemerle J
    Soins; 1979 Aug 5-20; 24(15-16):51-9. PubMed ID: 90390
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular distribution of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in blood cells.
    Ueda T; Nakamura T; Kagawa D; Yamamoto K; Uchida M; Sasada M; Uchino H
    Gan; 1983 Jun; 74(3):445-51. PubMed ID: 6884702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells.
    Lotero LA; Olmos G; Diez JC
    Biochim Biophys Acta; 2003 Mar; 1620(1-3):160-6. PubMed ID: 12595085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic aspects of enzyme replacement therapy. An evaluation of the immune response to unentrapped, erythrocyte- and liposome-entrapped enzyme in C3H/HeJ Gush mice.
    Hudson LD; Fiddler MB; Desnick RJ
    Birth Defects Orig Artic Ser; 1980; 16(1):163-78. PubMed ID: 6778523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.
    Mayhew E; Papahadjopoulos D; Rustum YM; Dave C
    Cancer Res; 1976 Dec; 36(12):4406-11. PubMed ID: 187321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained delivery of cytarabine-loaded vesicular phospholipid gels for treatment of xenografted glioma.
    Qi N; Cai C; Zhang W; Niu Y; Yang J; Wang L; Tian B; Liu X; Lin X; Zhang Y; Zhang Y; He H; Chen K; Tang X
    Int J Pharm; 2014 Sep; 472(1-2):48-55. PubMed ID: 24914829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.
    Hong F; Mayhew E
    Cancer Res; 1989 Sep; 49(18):5097-102. PubMed ID: 2766280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats.
    Parker RJ; Priester ER; Sieber SM
    Drug Metab Dispos; 1982; 10(1):40-6. PubMed ID: 6124381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes.
    Millán CG; Castañeda AZ; López FG; Marinero ML; Lanao JM; Arévalo M
    Drug Deliv; 2005; 12(6):409-16. PubMed ID: 16253957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization).
    Rabussay DP; Nanda GS; Goldfarb PM
    Technol Cancer Res Treat; 2002 Feb; 1(1):71-82. PubMed ID: 12614180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the rationale for chemotherapy of refractory choriocarcinoma].
    Katoh T; Ishige H; Kobayashi O; Takamizawa H
    Gan To Kagaku Ryoho; 1982 May; 9(5):815-21. PubMed ID: 6191704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines.
    Allen TM; McAllister L; Mausolf S; Gyorffy E
    Biochim Biophys Acta; 1981 May; 643(2):346-62. PubMed ID: 7225387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhancement of antitumor effects on urological cancer in vitro and in vivo by drugs entrapped in liposomes. II. Role of reticuloendothelial system].
    Hata M; Tachibana M; Deguchi N; Hayakawa M
    Nihon Hinyokika Gakkai Zasshi; 1985 Apr; 76(4):508-15. PubMed ID: 2411989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.